Ovarian cancer chemotherapy: carboplatin as standard

Lancet. 2002 Aug 17;360(9332):500-1. doi: 10.1016/s0140-6736(02)09757-x.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carboplatin / therapeutic use*
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Peptichemio / therapeutic use

Substances

  • Doxorubicin
  • Cyclophosphamide
  • Peptichemio
  • Carboplatin

Supplementary concepts

  • CAP protocol 2